Loading clinical trials...
Loading clinical trials...
Randomized clinical trial focusing on the effect of tailored information on Covid-19 for patients with chronic kidney disease stage 5 on health literacy, anxiety and self-perceived health.
This single-center randomized open clinical trial in persons with chronic kidney disease stage 5 investigates the effect of information about coronavirus targeted at the study population, using study specific information videos followed by a teach-back method. We measure digital, functional, interactive and critical health literacy, fear of coronavirus and self-perceived health at baseline and end-of-study. Patients are followed from May-July 2021 through February 2022 (study period 7-9 months).
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Akershus University Hospital
Lørenskog, Akershus, Norway
Start Date
April 14, 2021
Primary Completion Date
March 10, 2022
Completion Date
December 31, 2023
Last Updated
March 29, 2022
215
ESTIMATED participants
Tailored information
BEHAVIORAL
Lead Sponsor
Ivar Anders Eide
NCT06314503
NCT06863194
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions